6th TCR-Based Therapies Summit

2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immatics, Triumvira, Affini-T, CDR-Life, and TScan, along with a wealth of investment and partnerships amounting to over $700M, it's time to come together to relish in these breakthroughs, while pouring this energy into expanding TCR treatment potential.

The 6th TCR-Based Therapies Summit returns as the only TCR-specific platform for industry experts to join forces to share the technical insights to transform discovery, translation, R and D, and clinical development for cell- and biologic-based approaches.

Date and Time: Tuesday, 01 April 2025 at 08:00 to Thursday, 03 April 2025 at 16:30

Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States